Chemours
CC • NYSE
Chemours is a chemicals - specialty company in the basic materials sector trading on NYSE, led by CEO Denise Dignam, with a market cap of $3.2B.
CEODenise Dignam
Next Earnings
Upcoming earnings announcement for Chemours
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.06
Revenue Estimate
$1.4B
Earnings History
Past 12 earnings reports for Chemours
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | $0.05Est: $0.02 | +150.0% | $1.3BEst: $1.3B | -2.2% |  10-K |
| Nov 6, 2025 | Q3 2025 | $0.20Est: $0.24 | -16.7% | $1.5BEst: $1.5B | +0.0% | 10-Q |
| Aug 5, 2025 | Q2 2025 | $0.58Est: $0.46 | +26.1% | $1.6BEst: $1.6B | +3.0% | 10-Q |
| May 6, 2025 | Q1 2025 | $0.13Est: $0.20 | -35.0% | $1.4BEst: $1.4B | +1.3% | 10-Q |
| Feb 18, 2025 | Q4 2024 | $0.11Est: $0.16 | -31.3% | $1.4BEst: $1.4B | -0.8% | 10-K |
| Nov 4, 2024 | Q3 2024 | $0.40Est: $0.28 | +42.9% | $1.5BEst: $1.4B | +4.2% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $0.38Est: $0.57 | -33.3% | $1.5BEst: $1.5B | +0.5% | 10-Q |
| Apr 30, 2024 | Q1 2024 | $0.32Est: $0.18 | +77.8% | $1.4BEst: $1.4B | 0.0% | 10-Q |
| Mar 27, 2024 | Q4 2023 | $0.31Est: $0.25 | +24.0% | $1.4BEst: $1.3B | +3.1% | 10-K |
| Oct 26, 2023 | Q3 2023 | $0.63Est: $0.72 | -12.5% | $1.5BEst: $1.5B | -2.8% | 10-Q |
| Jul 27, 2023 | Q2 2023 | $1.10Est: $1.07 | +2.8% | $1.6BEst: $1.7B | -3.0% | — |
| Apr 27, 2023 | Q1 2023 | $0.98Est: $0.47 | +108.5% | $1.5BEst: $1.5B | +5.2% | — |